» Articles » PMID: 8759103

Class III Antiarrhythmic Effects of Zatebradine. Time-, State-, Use-, and Voltage-dependent Block of HKv1.5 Channels

Overview
Journal Circulation
Date 1996 Aug 1
PMID 8759103
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Zatebradine is a bradycardic agent that inhibits the hyperpolarization-activated current (I(f)) in the rabbit sinoatrial node. It also prolongs action potential duration in papillary muscles in guinea pigs and in Purkinje fibers in rabbits. The underlying mechanism by which zatebradine induces this effect has not been explored, but it is likely to involve K+ channel block.

Methods And Results: Cloned human cardiac K+ delayed rectifer currents (hKv1.5) were recorded in Ltk- cells transfected with their coding sequence. Zatebradine 10 mumol/L did not modify the initial activation time course of the current but induced a subsequent decline to a lower steady-state current level with a time constant of 109 +/- 16 ms. Zatebradine inhibited hKv1.5 with an apparent KD of 1.86 +/- 0.14 mumol/L. Block was voltage dependent (electrical distance delta = 0.177 +/- 0.003) and accumulated in a use-dependent manner during 0.5- and 1-Hz pulse trains because of slower recovery kinetics in the presence of the drug. Zatebradine reduced the tail current amplitude, recorded at -30 mV, and slowed the deactivation time course, which resulted in a "crossover" phenomenon when control and zatebradine tail currents were superimposed.

Conclusions: These results indicate that (1) zatebradine is an open-channel blocker of hKv 1.5, (2) binding occurs in the internal mouth of the ion pore, (3) unbinding is required before the channel can close, and (4) zatebradine-induced block is use dependent because of slower recovery kinetics in the presence of the drug. These effects may explain the prolongation of the cardiac action potential and could be clinically relevant.

Citing Articles

Screening effects of HCN channel blockers on sleep/wake behavior in zebrafish.

Doldur-Balli F, Smieszek S, Keenan B, Zimmerman A, Veatch O, Polymeropoulos C Front Neurosci. 2024; 18:1375484.

PMID: 38567282 PMC: 10986788. DOI: 10.3389/fnins.2024.1375484.


I current stabilizes excitability in rodent DRG neurons and reverses hyperexcitability in a nociceptive neuron model of inherited neuropathic pain.

Vasylyev D, Liu S, Waxman S J Physiol. 2023; 601(23):5341-5366.

PMID: 37846879 PMC: 10843455. DOI: 10.1113/JP284999.


Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels.

Lee H, Yoon S, Kim M, Hahn S, Choi B Korean J Physiol Pharmacol. 2022; 27(1):95-103.

PMID: 36575937 PMC: 9806636. DOI: 10.4196/kjpp.2023.27.1.95.


The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state.

Lee H, Hahn S, Choi B Korean J Physiol Pharmacol. 2022; 26(2):135-144.

PMID: 35203063 PMC: 8890944. DOI: 10.4196/kjpp.2022.26.2.135.


Bidirectional flow of the funny current (I) during the pacemaking cycle in murine sinoatrial node myocytes.

Peters C, Liu P, Morotti S, Gantz S, Grandi E, Bean B Proc Natl Acad Sci U S A. 2021; 118(28).

PMID: 34260402 PMC: 8285948. DOI: 10.1073/pnas.2104668118.